Huntington National Bank »

Intra Cellular Therapies shares owned by Huntington National Bank

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Huntington National Bank from 13F filings

Historical chart of Huntington National Bank investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Huntington National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Huntington National Bank

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.5k 1 2540.00
2025-06-30 $2.5k 1 2540.00
2025-03-31 $32k 244 131.92
2024-12-31 $36k 432 83.52
2024-09-30 $36k 486 73.17
2024-06-30 $29k 429 68.49
2024-03-31 $35k 508 69.20
2023-12-31 $35k 486 71.62
2023-09-30 $30k 575 52.09
2023-06-30 $42k 664 63.32
2023-03-31 $24k 447 54.15
2022-12-31 $19k 350 52.92
2022-09-30 $18k 384 46.88
2022-06-30 $21k 361 58.17
2022-03-31 $3.0k 46 65.22

More positions owned by Huntington National Bank

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Jp Morgan Chase & Co Common Stock (JPM)
Apple Common Stock (AAPL)
Alphabet Common Stock (GOOGL)
Vanguard Exchange Traded (Principal) (VEA)
Ishares Exchange Traded (Principal) (IVV)
Broadcom Common Stock (AVGO)
Amazon.com Common Stock (AMZN)
Ishares Exchange Traded (Principal) (IJH)
Meta Platforms Common Stock (META)
Netflix Common Stock (NFLX)
Ishares Exchange Traded (Principal) (IJR)
Exxon Mobil Corp Common Stock (XOM)
Eli Lilly & Co Common Stock (LLY)

View all positions for Huntington National Bank

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies